AHA Statement to the House E&C Health Subcommittee Re: "Examining the 340B Drug Pricing Program"

Comments of the 黑料正能量 Association on the value the 340B program provides to patients and communities.

Key Resources

Related Resources

Letter/Comment
AHA Comments on Medicare Transaction Facilitator Under Medicare Drug Price Negotiation Program
Public
Action Alert
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Member
Advisory
Updated Medicare Advantage Question and Complaint Process for Provider Organizations
Member
Case Studies
Johnson County Hospital | Nebraska
Public
Letter/Comment
AHA Supports House Securing Access to Care for Seniors in Critical Condition Act
Public
Advisory
CMS Issues Rate Announcement and Final Rule for CY 2026 Medicare Advantage, Prescription Drug Plans
Member